Tech Company Financing Transactions

Apellis Pharmaceuticals Funding Round

Sectoral Asset Management, Clough Capital Partners and Cormorant Asset Management participated in a $60 million Series E funding round for Apellis Pharmaceuticals. This venture round was recorded on 8/11/2017.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

6400 Westwind Way A
Crestwood, KY 40014
USA

Phone

(502) 241-4114

Website

www.apellis.com

Email Address

[email protected]

Overview

Apellis (NASDAQ: APLS) was founded in 2009. Apellis' approach is centered on the inhibition of the complement system, which is a cascade of interacting proteins and is an integral component of the immune system.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Cedric Francois

        

Chief Financial Officer

Timothy Sullivan

        

Chief Medical Officer

Federico Grossi

        

Chief Operating Officer

Pascal Deschatelets

        

VP - Finance

Nicole Perry

        

VP - General Counsel

David Watson

        

VP - Operations

Ahmad Sadr

        

Browse more venture capital transactions:

Prev: 8/11/2017: Auvik Networks venture capital transaction
Next: 8/11/2017: Coinbase venture capital transaction

Share this article

About Our Venture Capital Transactions Database

Our team works diligently to report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary